Article info

PDF

Original research article
Early clinical outcomes as a function of use of newer oral P2Y12 inhibitors versus clopidogrel in the EUROMAX trial

Authors

  1. Correspondence to Dr Gregory Ducrocq; gregory.ducrocq{at}aphp.fr
View Full Text

Citation

Huber K, Ducrocq G, Hamm CW, et al
Early clinical outcomes as a function of use of newer oral P2Y12 inhibitors versus clopidogrel in the EUROMAX trial

Publication History

  • Received June 13, 2017
  • Revision received August 16, 2017
  • Accepted September 12, 2017
  • Published online November 28, 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.